TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Diagnosis Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Thumb Arthritis Market, By Type
6.1 Introduction
6.2 Osteoarthritis Thumb Arthritis
Market Estimates & Forecast, 2023-2032
6.3 Rheumatoid Thumb Arthritis
Market Estimates & Forecast, 2023-2032
6.4 Others
Chapter 7. Global Thumb Arthritis Market, By Diagnosis
7.1 Introduction
7.2 Physical Examinations
Market Estimates & Forecast, 2023-2032
7.3 Imaging
Market Estimates & Forecast, 2023-2032
7.3.1 X-Ray
7.3.2 Computed Tomography (CT)
7.3.3 Magnetic Resonance Imaging (MRI)
7.3.4 Others
7.4 Fine Needle Aspiration (FNA)
Market Estimates & Forecast, 2023-2032
7.5 Others
Chapter 8. Global Thumb Arthritis Market, By Treatment
8.1 Introduction
8.2 Thumb Exercise
Market Estimates & Forecast, 2023-2032
8.3 Medication
Market Estimates & Forecast, 2023-2032
8.3.1 OCT Medications
8.3.1.1 Acetaminophen
8.3.1.2 Ibuprofen
8.3.1.3 Others
8.3.2 Prescription Medications
8.3.2.1 Celecoxib
8.3.2.2 Meloxicam
8.3.2.3 Others
8.4 Surgery
8.4.1 Trapeziectomy
8.4.2 Osteotomy
8.4.3 Others
8.5 Others
Chapter 9. Global Thumb Arthritis Market, By End Users
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, 2023-2032
9.3 Research Organizations
Market Estimates & Forecast, 2023-2032
9.4 Retail Pharmacies
Market Estimates & Forecast, 2023-2032
9.5 Others
Chapter 10. Global Thumb Arthritis Market, By Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest Of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic Of Korea
10.4.6 Rest Of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest Of The Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 BioPro
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 McKie Splints
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 AbbVie Inc.
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Amgen Inc.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial Overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Pfizer Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Carestream Health
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 General Electric Company
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs Of The Market
13.2 Key Companies To Watch
13.3 Prediction Of Thumb Arthritis Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Thumb Arthritis Industry Synopsis, 2023-2032
Table 2 Global Thumb Arthritis Market Estimates And Forecast, 2023-2032, (USD Million)
Table 3 Global Thumb Arthritis Market By Region, 2023-2032, (USD Million)
Table 4 Global Thumb Arthritis Market By Type, 2023-2032, (USD Million)
Table 5 Global Thumb Arthritis Market By Diagnosis, 2023-2032, (USD Million)
Table 6 Global Thumb Arthritis Market By Treatment, 2023-2032, (USD Million)
Table 7 Global Thumb Arthritis Market By End Users, 2023-2032, (USD Million)
Table 8 North America Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 9 North America Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 10 North America Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 11 North America Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 12 U.S. Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 13 U.S. Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 14 U.S. Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 15 U.S. Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 16 Canada Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 17 Canada Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 18 Canada Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 19 Canada Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 20 South America Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 21 South America Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 22 South America Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 23 South America Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 24 Europe Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 25 Europe Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 26 Europe Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 27 Europe Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 28 Western Europe Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 29 Western Europe Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 30 Western Europe Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 31 Western Europe Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 32 Eastern Europe Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 33 Eastern Europe Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 34 Eastern Europe Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 35 Eastern Europe Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 36 Asia Pacific Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 37 Asia Pacific Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 38 Asia Pacific Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 39 Asia Pacific Thumb Arthritis By End Users, 2023-2032, (USD Million)
Table 40 Middle East & Africa Thumb Arthritis By Type, 2023-2032, (USD Million)
Table 41 Middle East & Africa Thumb Arthritis By Diagnosis, 2023-2032, (USD Million)
Table 42 Middle East & Africa Thumb Arthritis By Treatment, 2023-2032, (USD Million)
Table 43 Middle East & Africa Thumb Arthritis By End Users, 2023-2032, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Thumb Arthritis Market
Figure 3 Market Dynamics For Global Thumb Arthritis Market
Figure 4 Global Thumb Arthritis Market Share, By Type 2020
Figure 5 Global Thumb Arthritis Market Share, By Diagnosis 2020
Figure 6 Global Thumb Arthritis Market Share, By Treatment, 2020
Figure 7 Global Thumb Arthritis Market Share, By End Users, 2020
Figure 8 Global Thumb Arthritis Market Share, By Region, 2020
Figure 9 North America Thumb Arthritis Share, By Country, 2020
Figure 10 Europe Thumb Arthritis Share, By Country, 2020
Figure 11 Asia Pacific Thumb Arthritis Share, By Country, 2020
Figure 12 Middle East & Africa Thumb Arthritis Share, By Country, 2020
Figure 13 Global Thumb Arthritis Market: Company Share Analysis, 2020 (%)
Figure 14 BioPro: Key Financials
Figure 15 BioPro: Segmental Revenue
Figure 16 BioPro: Geographical Revenue
Figure 17 McKie Splints: Type UK Ltd: Key Financials
Figure 18 McKie Splints: Type UK Ltd: Segmental Revenue
Figure 19 McKie Splints: Type UK Ltd: Geographical Revenue
Figure 20 AbbVie Inc.: Key Financials
Figure 21 AbbVie Inc.: Segmental Revenue
Figure 22 AbbVie Inc.: Geographical Revenue
Figure 23 F. Hoffmann-La Roche Ltd: Key Financials
Figure 24 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 25 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 26 Amgen Inc.: Key Financials
Figure 27 Amgen Inc.: Segmental Revenue
Figure 28 Amgen Inc.: Geographical Revenue
Figure 29 Pfizer Inc.: Key Financials
Figure 30 Pfizer Inc.: Segmental Revenue
Figure 31 Pfizer Inc.: Geographical Revenue
Figure 32 Carestream Health: Key Financials
Figure 33 Carestream Health: Segmental Revenue
Figure 34 Carestream Health: Geographical Revenue
Figure 35 General Electric Company: Key Financials
Figure 36 General Electric Company: Segmental Revenue
Figure 37 General Electric Company: Geographical Revenue